Oncocyte’s VitaGraftTM Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

Case Series represents second study showing VitaGraft Kidney as a measure of response to the benefit of therapy for one leading cause of allograft failure

Oncocyte’s VitaGraftTM Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million

SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products

AB INTL GROUP Reports of Financial Results for period ending May 31, 2024 and achieved Net Profitability

AB INTL GROUP Reports of Financial Results for period ending May 31, 2024 and achieved Net Profitability

StemSation International Provides Corporate Updates

StemSation International is providing updates on corporate planning and direction as they execute on an expanded business model

StemSation International Provides Corporate Updates

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Top Line Data Expected Year-End 2024

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Catch the Latest Buzz: Weekly News Release Highlights

Press Release Highlights - August 5 to August 9, 2024

ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides